Vascudyne Trademark Application - Vascular Health Biotechnology

ChangeBridge: Trademarks - Pharmaceuticals (Class 005)

Published March 14th, 2024

Detected April 1st, 2026

Summary

Vascudyne, a vascular health biotechnology company, filed Intent-to-Use trademark application TM98449022 with the USPTO on March 14, 2024. The application covers biotechnologically engineered tissue products including cells, tissue cell sheets, biological tissue grafts, and vascular grafts for medical purposes.

View original document View source feed page

What changed

Vascudyne filed USPTO Intent-to-Use trademark application TM98449022 on 2024-03-14. The application covers goods and services in Classes 5 (pharmaceuticals) and 10 (medical devices), specifically biotechnologically engineered tissue products including cells and tissue cell sheets for treating cardiac disease, biological tissue grafts, vascular grafts, surgical implants of living tissue, transcatheter implants, and related medical apparatus including cardiac valves, catheters, and cardiovascular prostheses.

This is an informational trademark filing notice with no compliance obligations for third parties. Biotechnology companies, medical device manufacturers, and pharmaceutical firms should note this application for competitive trademark monitoring purposes. The application status is 'intent to use,' indicating the mark has not yet been used in commerce.

Source document (simplified)

← USPTO Trademark Applications

VASCUDYNE

Intent to Use TM98449022 Kind: intenttouse Mar 31, 2026

Abstract

(Based on Intent To Use) Agents for medical purposes, namely, biotechnologically engineered tissue products in the nature of cells and tissue cell sheets for the treatment of cardiac disease and conditions; biological tissue implants comprising living tissue for medical and cosmetic purposes; biotechnologically engineered tissue products, namely, cells and tissue cell sheets for medical use; regenerative biological tissue sheets for medical purposes; surgical implants comprised of living tissue; transcatheter implants comprised of living tissue; biological material, namely, tissue sheets for the treatment of wounds; biological material, namely, cells and tissue cell sheets for the treatment of damaged skin and tissue; biological tissue grafts; vascular grafts; (Based on Intent To Use) Surgical apparatus; surgical apparatus for medical or veterinary use; medical and surgical apparatus, namely, implantable artificial cardiac valves; medical apparatus for use in percutaneous and endovascular procedures; medical apparatus for use in cardiovascular procedures; medical apparatus for treating cardiovascular disease; cardiac valves for surgical prostheses; prostheses for cardiovascular systems, namely, for the heart and heart valves; artificial cardiac valves for implantation as part of the cardiovascular system; subcutaneous valves comprised of artificial materials for implantation as part of the cardiovascular system; valve implants consisting of artificial materials for implementation as part of the cardiovascular system; medical devices for use in treating cardiac disease; replacement tissue valves being implants comprising artificial and natural, non-living materials for the human heart; catheters; (Based on Use in Commerce) Scientific research and development; biomedical research and development